- Having completed its $20 million placement, Oneview Healthcare (ONE) is now looking to raise another $3 million under a share purchase plan (SPP)
- The initial $20 million was raised by issuing 74 million new CHESS depository interests (CDIs) to institutional investors at $0.27 each
- Investors in Australia, New Zealand and Ireland have now been invited to purchase up to $30,000 worth of CDIs under the SPP
- The proceeds will be used to bolster sales and marketing initiatives, and to expand Oneview’s Cloud Enterprise
- Shares in Oneview Healthcare were down 3.7 per cent to $0.26 each at the close of trading on Wednesday
Having completed its $20 million placement, Oneview Healthcare (ONE) is now looking to raise another $3 million under a share purchase plan (SPP).
According to today’s announcement, the initial $20 million was raised by issuing just over 74 million new CHESS depository interests (CDIs) to institutional investors in Australia and across Asia at $0.27 each.
That price represents an 18.2 per cent discount to Oneview’s closing price on November 10, and a 20.8 per cent discount to its five-day volume weighted average price as of that date.
With “very strong support from existing institutional and sophisticated securityholders,” the CDIs will be issued in two separate tranches. The first accounts for roughly 65 million CDIs that were issued on November 19, while the issuance of the remaining nine million CDIs remains subject to shareholder approval at a meeting scheduled for Friday, December 17, 2021.
“This funding round comes at a time of great opportunity in healthcare, given the acceleration of digitalisation as a result of the pandemic,” CEO James Fitter said.
“As nurse and other hospital staffing pressures and shortages worsen, we are pleased that our solution can relieve some of their burden by providing digital tools to increase the efficiency and effectiveness of care for both patients and providers.”
Now, Oneview is looking to raise an additional $3 million under an SPP to eligible shareholders. Investors in Australia, New Zealand and Ireland have been invited to purchase up to $30,000 worth of new CDIs, also at $0.27 each.
Those CDIs purchased under the SPP are scheduled to be issued on December 21 this year.
Oneview said it will use the proceeds from both the placement and the SPP to expand its sales and marketing initiatives and to bolster the development of its Cloud Enterprise.
Shares in Oneview Healthcare were down 3.7 per cent to $0.26 each at the close of trading on Wednesday.